Evidence map›Paper›PMID 38931346›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Potential of Bioactive Protein and Protein Hydrolysate from

Paphawarin Thuraphan, Suphawan Suang, Anurak Bunrod, Watchara Kanjanakawinkul, Wantida Chaiyana

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paphawarin ThuraphanDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0009-0009-1923-9365
Suphawan SuangDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
Anurak BunrodChulabhorn Royal Pharmaceutical Manufacturing Facilities by Chulabhorn Royal Academy, Chon Buri 20180, Thailand.
Watchara KanjanakawinkulChulabhorn Royal Pharmaceutical Manufacturing Facilities by Chulabhorn Royal Academy, Chon Buri 20180, Thailand.
Wantida ChaiyanaDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-2868-7049

Funding

Center of Excellence in Pharmaceutical Nanotechnology, Chiang Mai UniversityChiang Mai University (CMU) Proactive Researcher, Chiang Mai University 762/2566Fundamental Fund 2023, Chiang Mai UniversityGraduate School, Chiang Mai UniversityMaster's Degree Program in Cosmetic Science, Faculty of Pharmacy, Chiang Mai University
6 · The paper itself

Abstract

This study aimed to extract bioactive proteins and protein hydrolysates from

Indexed as

alcalaseanti-ageingantioxidationApis melliferabee larvaecollagenasecosmeceuticalshyaluronidaselysineprotein hydrolysate

Identifiers

PMID38931346
PMCPMC11206733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.